Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Ebert

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cell Communication and Signaling : CCS|May 28, 2026
Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesisNachiyappan Venkatachalam, Li Wang, Niyumi Muthukumarana, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|February 2, 2022
[Current clinical research landscape in Germany-an interdisciplinary position paper]Viktor Grünwald, Wolfgang Bethge, Jens-Uwe Blohmer, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Molecular Oncology|February 24, 2026
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancerRodrigo Dienstmann, Eduardo García-Galea, Alice O'Farrell, et al.
JHEP Reports : Innovation in Hepatology|March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabSimon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cell Communication and Signaling : CCS|May 28, 2026
Ras-MAPK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesisNachiyappan Venkatachalam, Li Wang, Niyumi Muthukumarana, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|February 2, 2022
[Current clinical research landscape in Germany-an interdisciplinary position paper]Viktor Grünwald, Wolfgang Bethge, Jens-Uwe Blohmer, et al.
Science Immunology|May 3, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillanceMichael Kilian, Mirco J Friedrich, Kevin Hai-Ning Lu, et al.
Gut|January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Steven Dooley, Bedair Dewidar, et al.
Zeitschrift Fur Gastroenterologie|December 12, 2019
Markus Moehler, Salah-Edin Al-Batran, Tilo Andus, et al.
Molecular Oncology|February 24, 2026
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancerRodrigo Dienstmann, Eduardo García-Galea, Alice O'Farrell, et al.
JHEP Reports : Innovation in Hepatology|March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumabSimon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
Pageof 8